Featured
Last news
Drone flights 'most serious attack' on Danish infrastructure, PM says
Large drones that flew over Copenhagen airport for hours and caused it to shut down constituted the "most serious attack on Danish critical infrastructure" to date, Prime Minister Mette Frederiksen said Tuesday.
India bids tearful farewell to maverick musician
Tens of thousands of mourners thronged the streets of India's northeastern Assam state on Tuesday to bid farewell to a flamboyant artiste, celebrated as much for his music as for his irreverent persona.
Unification Church leader arrested in South Korea
The Unification Church leader was arrested Tuesday in South Korea over allegations of bribery linked to a former first lady, including luxury gifts, prosecutors said.
LiberNovo North American Pre-Sales Now Live With the First Dynamic Ergonomic Chair
From September 23 at 7:00 PM PDT through October 20, U.S. and Canadian customers can reserve Omni with an exclusive 5% new-customer discount (limited quantities) and receive a complimentary gift pack: eye mask, eco-bag, and foot cushion. Shipping begins October 20.
Viemed Healthcare Announces Completion of Share Repurchase Program
LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program.
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Full year fiscal 2025 net revenue of $66.4 millionFull year fiscal 2025 net loss of $13.6 millionFull year fiscal 2025 adjusted EBITDA1 of $9.2 million$31.0 million cash balance at June 30, 2025Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market with what the Company believes to be a novel first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDDCompany to host conference call and webcast today, September 23, 2025, at 4:30 p.m. Eastern time
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025.
Brag House and New to The Street Exploring Strategic Collaboration
NEW YORK, NY / ACCESS Newswire / September 23, 2025 / New to The Street, one of the fastest-growing financial media brands with over 3.5 million YouTube subscribers and weekly national broadcasts on Fox Business and Bloomberg, announced today it is in discussions with Brag House, a Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, to explore a potential strategic collaboration.
Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions
BOSTON, MA / ACCESS Newswire / September 23, 2025 / MEDevice Boston, the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote speakers for the 2025 conference. The event will take place September 30 - October 1, at the Boston Convention & Exhibition Center (BCEC). This year's keynote sessions will feature prominent thought leaders in healthcare advancements and device development, sharing insights on the future of MedTech and strategies for success in an evolving healthcare landscape.
42WEST, a Subsidiary of Dolphin, Drives Global Reveal of 30 Ninjas' Asteroid – Backed by Google's Android XR and CAA
Directed by Doug Liman, the Film Premiered in the Venice Immersive Competition at the 82nd Venice International Film Festival
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / September 23, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, September 25, 2025 at the Emerging Growth Conference and virtually on Tuesday, September 30, 2025 at the Lytham Partners Fall 2025 Conference.
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and present posters that underscore the Company's flexible nucleic acid production solutions designed to meet critical unmet needs for the manufacture of advanced biotherapeutics:
Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection
MESA, ARIZONA / ACCESS Newswire / September 23, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.
Nepra Foods Inc. Announces Exclusive North American Distribution Agreement for Award-Winning Naki Manuka Honey
VANCOUVER, BC / ACCESS Newswire / September 23, 2025 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF)(FSE:2P6) ("Nepra" or the "Company"), a pioneer in specialty and allergen-free food innovations driving healthier futures, announces an exclusive agreement between Nepra Foods Ltd. and Naki New Zealand, a premier family-owned producer of Unique Manuka Factor (UMF) certified Manuka honey. This strategic partnership positions Nepra as the sole North American distributor and sales team for Naki's Manuka honey products starting in Q4 2025. Further contract details remain confidential.
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groupsBoth of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients
Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has initiated the official approval process for its new product PulmoPlas® with the Federal Institute for Drugs and Medical Devices („Bundesinstitut für Arzneimittel und Medizinprodukte"; BfArM). With this step, the company is setting the course for the future widespread use of this novel therapy.
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term Revenue Opportunity
S. Korea court issues arrest warrant for Unification Church leader: Yonhap
A Seoul court on Tuesday issued an arrest warrant for Unification Church leader Han Hak-ja over allegations of bribery linked to a former first lady and incitement to destroy evidence, the Yonhap news agency reported.
UK charities axe Prince Andrew's ex-wife over Epstein email
Numerous UK charities Monday severed ties with Sarah Ferguson, the ex-wife of disgraced Prince Andrew, after a new email emerged in which she called convicted US sex offender Jeffrey Epstein a "supreme friend" and sought forgiveness for "letting him down".
Jews flock to Ukraine for New Year pilgrimage despite travel warning
Thousands of Orthodox Jews flocked to the Ukrainian city of Uman on Monday for the celebration of Rosh Hashanah, despite warnings from Kyiv not to travel due to the Russian invasion.
UK charity axes Prince Andrew's ex-wife over Epstein email
A UK children's charity said Monday that it had severed ties with Sarah Ferguson, the ex-wife of disgraced Prince Andrew, after an email emerged between her and convicted US sex offender Jeffrey Epstein.
Philippine protest arrests leave parents seeking answers
Anxious Filipino parents braved the rain outside Manila's police headquarters Monday, after more than 200 people -- including dozens of children -- were arrested in clashes that erupted during weekend anti-corruption demonstrations.
Google faces court battle over breakup of ad tech business
Google faces a fresh federal court test on Monday as US government lawyers ask a judge to order the breakup of the search engine giant's ad technology business.
Milan Fashion Week to mourn Armani, welcome new stars
Milan Fashion Week opens Tuesday, a feast of Italian style set to be dominated by the late Giorgio Armani's final collections and new faces at Gucci and Versace.
'No amnesty!' Brazilians protest against bid to pardon Bolsonaro
Tens of thousands of Brazilians protested Sunday against "shameless" lawmakers seeking an amnesty that could benefit former president Jair Bolsonaro, while pushing to shield themselves from criminal charges.
Most RPM & CCM Programs Create More Headaches Than Health
Connectivity failures, OS updates, and frustrated patients shouldn't be your problem. Silent devices, outsourced call centers, and disengaged patients create hidden risks and liability. Addison Care delivers fully integrated Virtual Care - engaging patients, protecting providers, and maximizing Medicare value.
Ambience Healthcare Announces Nikhil Buduma as New Chief Executive Officer
Co-Founder Mike Ng to take the role of President & Chairman
Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Michael Lock, Professor in the Department of Oncology and the Department of Medical Biophysics at the University of Western Ontario, to its Scientific and Clinical Advisory Board. Dr. Lock's expertise in clinical trial design, translational oncology, and multidisciplinary cancer care will support Onco in its development of novel therapies, including its PNKP inhibitor program.
NHI Prices Offering of Senior Notes
MURFREESBORO, TN / ACCESS Newswire / September 22, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it priced an offering of $350 million aggregate principal amount of 5.350% Senior Notes due 2033 (the "Notes"). The Notes will be issued at 98.903% of par value with a coupon of 5.350%. Interest on the Notes is payable semi-annually on February 1 and August 1 of each year, commencing February 1, 2026. The Notes will mature on February 1, 2033. The offering is expected to close on September 26, 2025, subject to the satisfaction of customary closing conditions.
Maison Solutions Reports First Quarter 2026 Financial Results
MONTEREY PARK, CA / ACCESS Newswire / September 22, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the first quarter ended July 31, 2025.